Albemarle Today
$131.52 +6.10 (+4.86%) As of 08/7/2026 03:59 PM Eastern
This is a fair market value price provided by Massive. Learn more. - 52-Week Range
- $71.25
▼
$221.00 - Dividend Yield
- 1.25%
- P/E Ratio
- 487.13
- Price Target
- $192.30
Albemarle NYSE: ALB faced high expectations heading into its
Q2 2026 earnings report. The stock was down over 30% from its 52-week high in June. ALB is also down over 50% from its all-time high in 2022. It hasn’t been an easy stock to hold, but the company’s earnings report illustrated why that’s a good strategy.
To sum it up, Albemarle’s adjusted earnings per share (EPS) were up over 3,300% year over year (YOY). That’s not a typo. The company generated adjusted EPS of $3.75, massively higher than the 11 cents per share from the prior year.
The gain was largely due to higher lithium prices. Still, the $3.75 in adjusted EPS was higher than the forecasted price of $3.20. This was a strong number, and it wasn’t the only one. Revenue of $1.74 billion beat expectations of $1.61 billion and was 30% higher YOY.
Albemarle Earnings Show Lithium Recovery Is Real
But the quarter wasn’t just about pricing power. After all, the price of lithium is down about 30% from a peak of nearly $30,000 per metric ton made earlier this year. That explains a significant reason for the dip in ALB stock.
But this is a moment when demand is reinforcing the case for owning a stake in the physical economy in 2026 and beyond. There may be some bumps along the way, but this is a long-term story with room to run.
Strong Execution Extends Beyond the EPS Beat
The EPS and revenue beats matter, but the details underneath tell a more durable story. Adjusted EBITDA came in at $858 million, up 155% year-over-year, and margin expanded to 49% from just 25% a year ago. The takeaway is that evidence of pricing gains is dropping to the bottom line rather than being absorbed by costs.
Albemarle also delivered roughly $100 million in cost and productivity run-rate improvements in the first half of 2026. The company is also on track to hit the high end of its $100-$150 million full-year target, with debottlenecking projects at La Negra, Jordan Bromine Company, and its Chinese conversion facilities cited as concrete drivers.
The company is also generating cash. Operating cash flow conversion hit 69% in the first half of 2026, trending toward the company's 60-70% long-term target after languishing as low as 37% in 2023. Free cash flow reached $638 million for the quarter. That backs up years of management assurances about self-funded growth.
Not everything was clean. Albemarle flagged an estimated $70-90 million unmitigated hit from Middle East-related supply chain disruptions, and narrowed full-year lithium sales volume guidance to 225-235 kilotons LCE after a fire delayed the CGP3 expansion at Greenbushes.
That plant restarted Aug. 1 and should reach full production by Q1 2027, with better-than-planned output at the Wodgina joint venture largely offsetting the delay. It’s a reminder that Albemarle's diversified asset base cushions single-site setbacks.
Why Lithium Demand Still Has Years of Growth Ahead
Lithium has become a foundational input to the physical economy. But it’s easy to overlook when the conversation stays fixated on software and AI. Every electric vehicle (EV), every grid-scale battery, and increasingly every data center backup system depends on lithium-ion chemistry.
Albemarle's own data shows global lithium consumption up 45% year-over-year through May. That’s ahead of the company's already bullish 15-40% forecast range.
The clearest driver is energy storage. Global Energy Storage Systems production has surged YOY in 2026, more than doubling at points earlier in the year, as utilities race to add capacity amid rising electricity demand. Some of that demand is coming from an unexpected place: AI data centers straining power grids, pushing automakers to repurpose EV battery lines for stationary storage instead.
Albemarle's long-term forecasts for stationary storage battery production growing at a 20-30% compound annual rate through 2030. The company also forecasts total lithium demand nearly doubling from 1.6 million metric tons LCE in 2025 to 3.6 million by 2030.
That's the raw material backbone for electrifying transportation, building grid resilience, and now powering AI infrastructure. Investing in Albemarle is driven by the belief that physical inputs will remain scarce relative to demand, regardless of quarter-to-quarter price swings in lithium.
Why Albemarle Still Belongs in a Long-Term Portfolio
Albemarle Stock Forecast Today
12-Month Stock Price Forecast:$192.3046.22% UpsideModerate BuyBased on 26 Analyst Ratings | Current Price | $131.52 |
|---|
| High Forecast | $250.00 |
|---|
| Average Forecast | $192.30 |
|---|
| Low Forecast | $85.00 |
|---|
Albemarle Stock Forecast DetailsIs the post-earnings rally in ALB the start of a larger bull case for Albemarle? The answer is yes, but maybe not quite yet. Investors should strongly consider investing in miners like Albemarle, which have direct exposure to the commodities sector.
While not a precious metal, lithium will remain in high demand, with supply likely to lag. Albemarle is at the center of that story, which is a key reason why analysts continue to raise their price targets for ALB.
For the long-term thesis to collapse, every lithium application, including electric vehicles, battery storage, and semiconductors, would have to show significant demand destruction. That seems unlikely.
But that doesn’t mean ALB won’t have volatility. Any stock that’s tied to a commodity will be a prisoner to that commodity’s price.
But that volatility works both ways, which makes the case for a buy-and-hold strategy with ALB. Although the 1.27% dividend yield may not attract many income investors, the company has a track record of raising its dividend for 30 straight years, supported by steady cash flow and projected earnings growth.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Albemarle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Albemarle wasn't on the list.
While Albemarle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report